Corvus Pharmaceuticals CEO and leadership

Richard A Miller is a co-founder, the president, and chief executive officer of [Corvus Pharmaceuticals](https://www.crunchbase.com/organization/corvus-pharmaceuticals#/entity), a clinical-stage biopharmaceutical company focused on the development of novel agents. Previously, he co-founded Pharmacyclics and served the same company as the chief executive officer. At Pharmacyclics, he led the initial discovery and development efforts for ibrutinib. Prior to co-founding Pharmacyclics, Miller co-founded IDEC and held various leadership roles as vice president and director at the same company. He has also founded other private and public biotech companies. Miller holds a Doctor of Medicine degree, summa cum laude, from the State University of New York Medical School and is currently Adjunct Clinical Professor of Medicine at Stanford University Medical Center.

Leiv Lea are a CFO/Treasurer/Co-Founder at Corvus Pharmaceuticals. They have worked as Interim CFO at BMC Software, Interim CFO at Various Companies, and Acting Chief Financial Officer at Global Village Communication. Leiv studied at UC Davis between 1971 and 1975 and UCLA Anderson School of Management between 1977 and 1979.

Richard A Miller is a co-founder, the president, and chief executive officer of [Corvus Pharmaceuticals](https://www.crunchbase.com/organization/corvus-pharmaceuticals#/entity), a clinical-stage biopharmaceutical company focused on the development of novel agents. Previously, he co-founded Pharmacyclics and served the same company as the chief executive officer. At Pharmacyclics, he led the initial discovery and development efforts for ibrutinib. Prior to co-founding Pharmacyclics, Miller co-founded IDEC and held various leadership roles as vice president and director at the same company. He has also founded other private and public biotech companies. Miller holds a Doctor of Medicine degree, summa cum laude, from the State University of New York Medical School and is currently Adjunct Clinical Professor of Medicine at Stanford University Medical Center.

Leiv Lea are a CFO/Treasurer/Co-Founder at Corvus Pharmaceuticals. They have worked as Interim CFO at BMC Software, Interim CFO at Various Companies, and Acting Chief Financial Officer at Global Village Communication. Leiv studied at UC Davis between 1971 and 1975 and UCLA Anderson School of Management between 1977 and 1979.

Richard A Miller is a co-founder, the president, and chief executive officer of [Corvus Pharmaceuticals](https://www.crunchbase.com/organization/corvus-pharmaceuticals#/entity), a clinical-stage biopharmaceutical company focused on the development of novel agents. Previously, he co-founded Pharmacyclics and served the same company as the chief executive officer. At Pharmacyclics, he led the initial discovery and development efforts for ibrutinib. Prior to co-founding Pharmacyclics, Miller co-founded IDEC and held various leadership roles as vice president and director at the same company. He has also founded other private and public biotech companies. Miller holds a Doctor of Medicine degree, summa cum laude, from the State University of New York Medical School and is currently Adjunct Clinical Professor of Medicine at Stanford University Medical Center.